Deal Announcements

BiOptix Garners Venture Capital Equity Funding

Friday, March 15, 2013 5:33:00 AM PDT | VentureDeal

   Boulder, Colorado  --  Medical diagnostics company BiOptix Diagnostics has received $6.2 million in new venture capital equity funding, according to an SEC regulatory filing.

BiOptix is developing its proprietary Enhanced Surface Plasmon Resonance platform to detect molecular interactions.

Investors in the financing were not disclosed, nor was how the company plans to use the proceeds.

BiOptix is still seeking $1.8 million in additional financing, according to the filing.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1